Andrew Conway Morris

Dr. Andrew Conway Morris is a Researcher at the Department of Pathology, University of Cambridge. He serves as an Honorary Consultant in Intensive Care Medicine at Addenbrooke's Hospital and leads the Conway Group focusing on immune dysfunction in critical illness.

• Role: MRC Clinician Scientist
• Location: Laboratory Block, Addenbrooke's Hospital, Cambridge Biomedical Campus

Research Interests include:

• Neutrophil biology and phagosomal maturation
• Host-microbe interactions in pneumonia and sepsis
• Immune dysfunction in critical illness via C5a and PI3Kδ pathways
• Molecular diagnostics for infections
• Translational immunology to clinical trials (e.g., GM-CSF therapy)

Scientific Output spans 2025-2020 publications on topics like:

• Subphenotyping severe infections
• Immune modulation in respiratory failure
• Metabolic and phosphoproteomic profiling
• Antibiotic stewardship and ICU sustainability

Awards:

• MRC Clinician Scientist Fellowship

Education & Training: As an MRC-funded clinician scientist, he bridges clinical practice (intensive care) with fundamental research on immune cell signaling.

Collaborations: Works with Professor Klaus Okkenhaug (Immunology), Dr. Betty Chung (Microbiology), and global critical care networks.